67 related articles for article (PubMed ID: 2568210)
1. Assessment of MK-912, an alpha 2-adrenoceptor antagonist, with use of intravenous clonidine.
Warren JB; Dollery CT; Fuller RW; Williams VC; Gertz BJ
Clin Pharmacol Ther; 1989 Jul; 46(1):103-9. PubMed ID: 2568210
[TBL] [Abstract][Full Text] [Related]
2. Assessment of MK-467, a peripheral alpha 2-adrenergic receptor antagonist, with intravenous clonidine.
Warren JB; Dollery CT; Sciberras D; Goldberg MR
Clin Pharmacol Ther; 1991 Jul; 50(1):71-7. PubMed ID: 1677320
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of the effects of clonidine by the alpha 2-adrenoceptor antagonist, fluparoxan.
Johnson MA; Blackwell CP; Smith J
Br J Clin Pharmacol; 1995 May; 39(5):477-83. PubMed ID: 7669482
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of a benzofuroquinolizine alpha 2-adrenoceptor antagonist.
Gertz BJ; Vlasses PH; Rocci ML; Coker LD; Williams V; Bjornsson TD; Jones KH
Clin Pharmacol Ther; 1989 Nov; 46(5):566-75. PubMed ID: 2573444
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological effects and pharmacokinetics of atipamezole, a novel alpha 2-adrenoceptor antagonist--a randomized, double-blind cross-over study in healthy male volunteers.
Karhuvaara S; Kallio A; Scheinin M; Anttila M; Salonen JS; Scheinin H
Br J Clin Pharmacol; 1990 Jul; 30(1):97-106. PubMed ID: 1975199
[TBL] [Abstract][Full Text] [Related]
6. Effect of an oral alpha 2-adrenergic blocker (MK-912) on pancreatic islet function in non-insulin-dependent diabetes mellitus.
Ortiz-Alonso FJ; Herman WH; Gertz BJ; Williams VC; Smith MJ; Halter JB
Metabolism; 1991 Nov; 40(11):1160-7. PubMed ID: 1682787
[TBL] [Abstract][Full Text] [Related]
7. The effects of a peripherally selective alpha 2-adrenoceptor antagonist, MK-467, on the metabolic and cardiovascular response to exercise in healthy man.
Sciberras DG; Reed JW; Elliott C; Blain PG; Goldberg MR
Br J Clin Pharmacol; 1994 Jan; 37(1):39-44. PubMed ID: 7908531
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the alpha 2-adrenoceptor blocking properties of buspirone and ipsapirone in healthy subjects. Relationship with the plasma concentration of the common metabolite 1-(2-pyrimidinyl)-piperazine.
Berlin I; Chalon S; Payan C; Schöllnhammer G; Cesselin F; Varoquaux O; Puech AJ
Br J Clin Pharmacol; 1995 Mar; 39(3):243-9. PubMed ID: 7619663
[TBL] [Abstract][Full Text] [Related]
9. Rapid reversal of alpha 2-adrenoceptor agonist effects by atipamezole in human volunteers.
Karhuvaara S; Kallio A; Salonen M; Tuominen J; Scheinin M
Br J Clin Pharmacol; 1991 Feb; 31(2):160-5. PubMed ID: 1675577
[TBL] [Abstract][Full Text] [Related]
10. A preliminary, clinical pharmacological assessment of L-659,066, a novel alpha 2-adrenoceptor antagonist.
Schafers RF; Elliott HL; Howie CA; Reid JL
Br J Clin Pharmacol; 1992 Dec; 34(6):521-6. PubMed ID: 1362887
[TBL] [Abstract][Full Text] [Related]
11. [Oral premedication with clonidine as an alternative in dental practice. The effects on the pain threshold, blood pressure and salivary flow].
Fanini D; Poglio M; Marci MC; Iovinelli G; Antenucci F
Minerva Stomatol; 1998 Sep; 47(9):453-64. PubMed ID: 9835755
[TBL] [Abstract][Full Text] [Related]
12. The sedative and sympatholytic effects of oral tizanidine in healthy volunteers.
Miettinen TJ; Kanto JH; Salonen MA; Scheinin M
Anesth Analg; 1996 Apr; 82(4):817-20. PubMed ID: 8615503
[TBL] [Abstract][Full Text] [Related]
13. Studies with abanoquil (UK-52,046) a novel quinoline alpha 1-adrenoceptor antagonist: I. Effects on blood pressure, heart rate and pressor responsiveness in normotensive subjects.
Schafers RF; Elliott HL; Howie CA; Reid JL
Br J Clin Pharmacol; 1991 Nov; 32(5):599-604. PubMed ID: 1683249
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of alpha adrenoceptors involved in the antinociceptive and cardiovascular effects of intrathecally administered clonidine.
Solomon RE; Brody MJ; Gebhart GF
J Pharmacol Exp Ther; 1989 Oct; 251(1):27-38. PubMed ID: 2571720
[TBL] [Abstract][Full Text] [Related]
15. Effects of intravenous and oral clonidine on hemodynamic and plasma-catecholamine response due to endotracheal intubation.
Zalunardo MP; Zollinger A; Spahn DR; Seifert B; Radjaipour M; Gautschi K; Pasch T
J Clin Anesth; 1997 Mar; 9(2):143-7. PubMed ID: 9075040
[TBL] [Abstract][Full Text] [Related]
16. Alpha 2-adrenoceptor-blocking properties of midaglizole (DG-5128) in rats.
Hirohashi M; Tanaka M; Suzuki I; Akashi A
Arch Int Pharmacodyn Ther; 1990; 306():75-86. PubMed ID: 1981668
[TBL] [Abstract][Full Text] [Related]
17. Intravenous administration of clonidine reduces intraocular pressure and alters ocular blood flow.
Weigert G; Resch H; Luksch A; Reitsamer HA; Fuchsjager-Mayrl G; Schmetterer L; Garhofer G
Br J Ophthalmol; 2007 Oct; 91(10):1354-8. PubMed ID: 17537785
[TBL] [Abstract][Full Text] [Related]
18. Clonidine inhibits the canine external carotid vasodilatation to capsaicin by alpha2A/2C-adrenoceptors.
Jiménez-Mena LR; Gupta S; Muñoz-Islas E; Lozano-Cuenca J; Sánchez-López A; Centurión D; Mehrotra S; MaassenVanDenBrink A; Villalón CM
Eur J Pharmacol; 2006 Aug; 543(1-3):68-76. PubMed ID: 16814767
[TBL] [Abstract][Full Text] [Related]
19. Objective assessment of clonidine analgesia in man and influence of naloxone.
Porchet HC; Piletta P; Dayer P
Life Sci; 1990; 46(14):991-8. PubMed ID: 2182959
[TBL] [Abstract][Full Text] [Related]
20. Lack of effect of the alpha-adrenergic agonist clonidine on pulsatile luteinizing hormone secretion in a double blind study in men.
Kaufman JM; Vermeulen A
J Clin Endocrinol Metab; 1989 Jan; 68(1):219-22. PubMed ID: 2642486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
